Clincosm LogoSign in Get a demo

cutaneous melanoma

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)

Not yet recruiting
  • Cutaneous Melanoma
  • +2 more
  • Exercise Test
  • Orlando, Florida
    AdventHealth Translational Research Institute
Aug 18, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

Recruiting
  • Melanoma (Skin)
  • +4 more
  • Bloomington, Minnesota
  • +7 more
Jan 31, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

Recruiting
  • Cervical Cancer
  • +5 more
  • Chicago, Illinois
  • +3 more
Jan 24, 2023

Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

Active, not recruiting
  • Cutaneous Melanoma
  • +5 more
  • Birmingham, Alabama
  • +13 more
Jan 23, 2023

Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

Recruiting
  • Cutaneous Melanoma
  • +4 more
  • Denver, Colorado
    Sarah Cannon Research Institute at HealthONE - Denver
Jan 17, 2023

Cutaneous Melanoma Trial in Portland (Training and Education)

Not yet recruiting
  • Cutaneous Melanoma
  • Training and Education
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 29, 2022

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Terminated
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Dec 7, 2022

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

Recruiting
  • Cutaneous Melanoma
  • Blood sample
  • Cutaneous melanoma biopsy
  • Paris, Ile De France, France
    Dermatology department
Oct 24, 2022

Cutaneous Melanoma, Melanocytic Nevus, Skin Carcinoma Trial in Portland (other, procedure, drug)

Recruiting
  • Cutaneous Melanoma
  • +2 more
  • Confocal Microscopy
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 17, 2022

Cutaneous Melanoma, Uveal Melanoma, Mucosal Melanoma Trial in Worldwide (RO7293583, Tocilizumab, Obinutuzumab)

Completed
  • Cutaneous Melanoma
  • +2 more
  • Boston, Massachusetts
  • +13 more
Sep 30, 2022

Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Tampa (Excerise, Checkpoint Blockade,

Recruiting
  • Cutaneous Melanoma
  • +2 more
  • Excerise
  • Checkpoint Blockade, Immune
  • Tampa, Florida
    Moffitt Cancer Center
Sep 21, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Cutaneous Melanoma, Mucosal Melanoma Trial in Worldwide (Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous)

Recruiting
  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Nemvaleukin Alfa Subcutaneous
  • Nemvaleukin Alfa Intravenous
  • La Jolla, California
  • +26 more
Aug 1, 2022

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Frequency and Clinical Phenotype of BAP1 Hereditary

Recruiting
  • Uveal Melanoma
  • +7 more
    • Columbus, Ohio
      The Ohio State University Wexner Medical Center
    Jul 6, 2022

    Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

    Recruiting
    • Solid Tumor
    • +8 more
    • Los Angeles, California
    • +5 more
    Jun 27, 2022

    Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

    Recruiting
    • Metastatic Uveal Melanoma
    • +3 more
    • Scottsdale, Arizona
    • +13 more
    May 10, 2022

    Cutaneous Melanoma Trial in Copenhagen (The MelaCare intervention)

    Recruiting
    • Cutaneous Melanoma
    • The MelaCare intervention
    • Copenhagen, Denmark
      Herlev and Gentofte Hospital
    Mar 11, 2022